Jump to:
loading...| Preferred Name | Sitagliptin | |
| Synonyms |
|
|
| Definitions |
An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C73838 |
|
| CAS_Registry |
486460-32-6 |
|
| CHEBI_ID |
CHEBI:40237 |
|
| Chemical_Formula |
C16H15F6N5O |
|
| code |
C73838 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
| Display_Name |
Sitagliptin |
|
| FDA_UNII_Code |
QFP0P1DV7Z |
|
| Has_Salt_Form | ||
| Has_Target | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 |
|
| label |
Sitagliptin |
|
| Legacy Concept Name |
Sitagliptin |
|
| Preferred_Name |
Sitagliptin |
|
| prefixIRI |
NCIT:C73838 |
|
| prefLabel |
Sitagliptin |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1565750 |
|
| subClassOf |
Create mapping